T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
UDR
UDR
$12.9B
| $15.7M | ﹤0.01% |
409,537
+10,253
| +3% | +$393K |
|
1002
First American
FAF
$6.93B
| $15.7M | ﹤0.01% |
243,000
-12,522
| -5% | -$807K |
|
1003
Doximity
DOCS
$13.2B
| $15.6M | ﹤0.01% |
557,636
-93,878
| -14% | -$2.63M |
|
1004
Silicon Laboratories
SLAB
$4.45B
| $15.5M | ﹤0.01% |
117,316
+68,285
| +139% | +$9.03M |
|
|
AMAM
1005
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $15.4M | ﹤0.01% |
1,084,247
+262,683
| +32% | +$3.74M |
|
1006
Voya Financial
VOYA
$7.39B
| $15.4M | ﹤0.01% |
211,412
+41,439
| +24% | +$3.02M |
|
1007
Molson Coors Class B
TAP
$9.71B
| $15.4M | ﹤0.01% |
250,809
+5,389
| +2% | +$330K |
|
1008
iShares MSCI EAFE ETF
EFA
$67.3B
| $15.2M | ﹤0.01% |
201,924
+201,414
| +39,493% | +$15.2M |
|
1009
Brookfield Renewable
BEP
$7.11B
| $15.1M | ﹤0.01% |
576,113
-12,255
| -2% | -$322K |
|
1010
SLM Corp
SLM
$6.05B
| $15.1M | ﹤0.01% |
790,210
+316,730
| +67% | +$6.06M |
|
1011
Henry Schein
HSIC
$8.43B
| $15.1M | ﹤0.01% |
199,164
+362
| +0.2% | +$27.4K |
|
1012
Travel + Leisure Co
TNL
$4.11B
| $15M | ﹤0.01% |
384,907
-147,263
| -28% | -$5.76M |
|
1013
Zoom
ZM
$25.4B
| $15M | ﹤0.01% |
208,595
-1,098,253
| -84% | -$79M |
|
1014
Crown Holdings
CCK
$11.4B
| $14.9M | ﹤0.01% |
162,089
+8,948
| +6% | +$824K |
|
1015
iShares Core MSCI EAFE ETF
IEFA
$153B
| $14.9M | ﹤0.01% |
212,100
+34,552
| +19% | +$2.43M |
|
1016
Qorvo
QRVO
$8.12B
| $14.7M | ﹤0.01% |
130,762
+4,806
| +4% | +$541K |
|
1017
Tenaya Therapeutics
TNYA
$209M
| $14.7M | ﹤0.01% |
4,544,543
+69,377
| +2% | +$225K |
|
1018
Skechers
SKX
$9.49B
| $14.7M | ﹤0.01% |
235,741
+1,253
| +0.5% | +$78.1K |
|
1019
Sana Biotechnology
SANA
$875M
| $14.7M | ﹤0.01% |
3,594,025
-3,432,116
| -49% | -$14M |
|
1020
Riot Platforms
RIOT
$5.78B
| $14.5M | ﹤0.01% |
938,205
+845,204
| +909% | +$13.1M |
|
1021
Healthpeak Properties
DOC
$12.6B
| $14.5M | ﹤0.01% |
732,295
-5
| -0% | -$99 |
|
1022
Moog
MOG.A
$6.38B
| $14.5M | ﹤0.01% |
100,015
-28,085
| -22% | -$4.07M |
|
1023
C4 Therapeutics
CCCC
$194M
| $14.5M | ﹤0.01% |
2,558,480
+372,021
| +17% | +$2.1M |
|
1024
Ardelyx
ARDX
$1.61B
| $14.4M | ﹤0.01% |
2,329,266
+597,099
| +34% | +$3.7M |
|
1025
Oscar Health
OSCR
$5.02B
| $14.4M | ﹤0.01% |
1,568,992
+704,913
| +82% | +$6.45M |
|